Reply to Caccialanza et al

A double-blind phase III trial of immunomodulating nutritional formula during adjuvant chemoradiotherapy in head and neck cancer patients: IMPATOX. Boisselier P, Kaminsky MC, Thézenas S, Gallocher O, Lavau-Denes S, Garcia-Ramirez M, Alfonsi M, Cupissol D, de Forges H, Janiszewski C, Geoffrois L, Sir...

Full description

Saved in:
Bibliographic Details
Published inThe American journal of clinical nutrition Vol. 113; no. 4; pp. 1054 - 1055
Main Authors Boisselier, Pierre, Thézénas, Simon, Flori, Nicolas, Vinches, Marie, Bourhis, Jean, Senesse, Pierre
Format Journal Article
LanguageEnglish
Published United States Oxford University Press 06.04.2021
American Society for Clinical Nutrition, Inc
Subjects
Chemoradiotherapy, Adjuvant
Double-Blind Method
Head and Neck Neoplasms
Humans
Life Sciences
Online AccessGet full text

Cover

More Information
Summary:A double-blind phase III trial of immunomodulating nutritional formula during adjuvant chemoradiotherapy in head and neck cancer patients: IMPATOX. Boisselier P, Kaminsky MC, Thézenas S, Gallocher O, Lavau-Denes S, Garcia-Ramirez M, Alfonsi M, Cupissol D, de Forges H, Janiszewski C, Geoffrois L, Sire C, Senesse P; Head and Neck Oncology and Radiotherapy Group (GORTEC). Am J Clin Nutr. 2020 Dec 10;112(6):1523-1531. doi: 10.1093/ajcn/nqaa227. PMID: 32936874 Clinical Trial. Immunonutrition in head and neck cancer patients undergoing chemoradiotherapy: an alternative approach for overcoming potential bias. Caccialanza R, Cereda E, Orlandi E, Filippi AR, Comoli P, Alberti A, Imarisio I, Pedrazzoli P, Bossi P. Am J Clin Nutr. 2021 Apr 6;113(4):1053-1054. doi: 10.1093/ajcn/nqaa421. PMID: 33822867 No abstract available.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Commentary-3
content type line 23
ISSN:0002-9165
1938-3207
DOI:10.1093/ajcn/nqaa425